|
|
|
|
|
|
|
|
|
|
Previous: INVERNESS MEDICAL TECHNOLOGY INC/DE, 10-Q, EX-10.1, 2000-11-01 |
Next: INVERNESS MEDICAL TECHNOLOGY INC/DE, 8-K, 2000-11-01 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 6,139,848
<SECURITIES> 0
<RECEIVABLES> 30,921,308
<ALLOWANCES> 5,771,000
<INVENTORY> 13,430,146
<CURRENT-ASSETS> 46,285,578
<PP&E> 20,078,532
<DEPRECIATION> 7,706,951
<TOTAL-ASSETS> 119,856,451
<CURRENT-LIABILITIES> 62,830,717
<BONDS> 18,894,535
4,327,561
0
<COMMON> 25,832
<OTHER-SE> 33,332,894
<TOTAL-LIABILITY-AND-EQUITY> 119,856,451
<SALES> 121,070,826
<TOTAL-REVENUES> 121,317,785
<CGS> 70,595,222
<TOTAL-COSTS> 38,388,677
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 5,898,187
<INCOME-PRETAX> 8,475,261
<INCOME-TAX> 434,761
<INCOME-CONTINUING> 8,040,500
<DISCONTINUED> 0
<EXTRAORDINARY> (799,729)
<CHANGES> 0
<NET-INCOME> 7,240,771
<EPS-BASIC> 0.30
<EPS-DILUTED> 0.26
</TABLE>
|
|